Fennec Pharmaceuticals Inc Share Price Today: Live Updates & Key Insights
Fennec Pharmaceuticals Inc share price today is $9.99, up -1.58%. The stock opened at $10.07 against the previous close of $10.15, with an intraday high of $10.19 and low of $9.985.
Fennec Pharmaceuticals Inc Share Price Chart
Fennec Pharmaceuticals Inc
Fennec Pharmaceuticals Inc Share Price Performance
Fennec Pharmaceuticals Inc Institutional Holdings
Fennec Pharmaceuticals Inc Market Status
Fennec Pharmaceuticals Inc Fundamentals
Market Cap 352.58 M
PB Ratio 9.3585
PE Ratio 0.0
Enterprise Value 330.88 M
Total Assets 70.07 M
Volume 90005
Fennec Pharmaceuticals Inc Company Financials
About Fennec Pharmaceuticals Inc & investment objective
Company Information Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Organisation Biotechnology
Employees 35
Industry Biotechnology
CEO Mr. Jeffrey S. Hackman
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Fennec Pharmaceuticals Inc FAQs
What is the share price of Fennec Pharmaceuticals Inc today?
The current share price of Fennec Pharmaceuticals Inc is $9.99.
Can I buy Fennec Pharmaceuticals Inc shares in India?
Yes, Indian investors can buy Fennec Pharmaceuticals Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Fennec Pharmaceuticals Inc shares in India?
You can easily invest in Fennec Pharmaceuticals Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Fennec Pharmaceuticals Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Fennec Pharmaceuticals Inc.
Can I buy fractional shares of Fennec Pharmaceuticals Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Fennec Pharmaceuticals Inc?
Fennec Pharmaceuticals Inc has a market cap of $352.58 M.
In which sector does Fennec Pharmaceuticals Inc belong?
Fennec Pharmaceuticals Inc operates in the Biotechnology sector.
What documents are required to invest in Fennec Pharmaceuticals Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Fennec Pharmaceuticals Inc?
The PE ratio of Fennec Pharmaceuticals Inc is N/A and the PB ratio is 9.36.